Jiangsu Hualan New Pharmaceutical MaterialLtd Past Earnings Performance
Past criteria checks 0/6
Jiangsu Hualan New Pharmaceutical MaterialLtd's earnings have been declining at an average annual rate of -8.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 2% per year. Jiangsu Hualan New Pharmaceutical MaterialLtd's return on equity is 3.6%, and it has net margins of 13.7%.
Key information
-8.4%
Earnings growth rate
-15.9%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 2.0% |
| Return on equity | 3.6% |
| Net Margin | 13.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Jiangsu Hualan New Pharmaceutical MaterialLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 592 | 81 | 128 | 40 |
| 30 Jun 24 | 604 | 95 | 135 | 38 |
| 31 Mar 24 | 593 | 95 | 142 | 39 |
| 31 Dec 23 | 623 | 118 | 144 | 36 |
| 30 Sep 23 | 631 | 106 | 161 | 36 |
| 30 Jun 23 | 619 | 98 | 156 | 37 |
| 31 Mar 23 | 610 | 96 | 149 | 36 |
| 01 Jan 23 | 584 | 94 | 141 | 37 |
| 30 Sep 22 | 586 | 108 | 132 | 39 |
| 30 Jun 22 | 691 | 164 | 135 | 41 |
| 31 Mar 22 | 784 | 206 | 142 | 44 |
| 01 Jan 22 | 821 | 216 | 144 | 42 |
| 30 Sep 21 | 784 | 214 | 122 | 37 |
| 30 Jun 21 | 633 | 151 | 108 | 31 |
| 31 Mar 21 | 509 | 103 | 88 | 25 |
| 31 Dec 20 | 446 | 81 | 77 | 24 |
| 31 Dec 19 | 460 | 95 | 89 | 20 |
| 31 Dec 18 | 434 | 86 | 79 | 21 |
| 31 Dec 17 | 388 | 77 | 68 | 16 |
Quality Earnings: 301093 has a large one-off gain of CN¥19.4M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 301093's current net profit margins (13.7%) are lower than last year (16.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301093's earnings have declined by 8.4% per year over the past 5 years.
Accelerating Growth: 301093's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301093 had negative earnings growth (-24%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 301093's Return on Equity (3.6%) is considered low.